Dr. Cohen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
128 Post Ave
Suite K
New York, NY 10034Phone+1 212-942-8744Fax+1 212-942-8744
Education & Training
- SUNY Downstate Health Sciences UniversityFellowship, Pediatric Critical Care Medicine, 1982 - 1984
- Icahn School of Medicine at Mount SinaiResidency, Pediatrics, 1980 - 1982
- Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalInternship, Pediatrics, 1979 - 1980
- Sapienza University of RomeClass of 1979
Certifications & Licensure
- NY State Medical License 1981 - 2025
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
Publications & Presentations
PubMed
- 15 citationsEfficacy and safety of Sandoz biosimilar rituximab for active rheumatoid arthritis: 52-week results from the randomized controlled ASSIST-RA trialJosef S Smolen, Stanley Cohen, Hans-Peter Tony, Morton Scheinberg, Alan Kivitz
Rheumatology. 2021-01-05 - 17 citationsLong-term safety, efficacy, and immunogenicity of adalimumab biosimilar BI 695501 and adalimumab reference product in patients with moderately-to-severely active rheum...Stanley Cohen, Niklas Czeloth, Eric Lee, Piotr Adrian Klimiuk, Nuala Peter
Expert Opinion on Biological Therapy. 2019-08-06 - 18 citationsBrief Report: Safety and Immunogenicity of Rituximab Biosimilar GP 2013 After Switch From Reference Rituximab in Patients With Active Rheumatoid Arthritis.Hans-Peter Tony, Klaus Krüger, Stanley Cohen, Hendrik Schulze-Koops, Alan Kivitz
Arthritis Care & Research. 2019-01-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: